Rationale: Gitelman syndrome (GS) is an autosomal recessive tubulopathy caused by mutations of the SLC12A3 gene. It is characterized by hypokalemic metabolic alkalosis, hypomagnesemia and hypocalciuria. Hypokalemia, hypomagnesemia, and increased renin-angiotensin-aldosterone system (RAAS) activity can cause glucose metabolism dysfunction. The diagnosis of GS includes clinical diagnosis, genetic diagnosis and functional diagnosis. The gene diagnosis is the golden criterion while as functional diagnosis is of great value in differential diagnosis. The hydrochlorothiazide (HCT) test is helpful to distinguish GS from batter syndrome, but few cases have been reported to have HCT testing.
Patient Concerns: A 51-year-old Chinese woman presented to emergency department because of intermittent fatigue for more than 10 years.
Diagnoses: Laboratory test results showed hypokalemia, hypomagnesemia, hypocalciuria and metabolic alkalosis. The HCT test showed no response. Using next-generation and Sanger sequencing, we identified 2 heterozygous missense variants (c.533C > T:p.S178L and c.2582G > A:p.R861H) in the SLC12A3 gene. In addition, the patient was diagnosed with type 2 diabetes mellitus 7 years ago. Based on these findings, the patient was diagnosed with GS with type 2 diabetic mellitus (T2DM).
Interventions: She was given potassium and magnesium supplements, and dapagliflozin was used to control her blood glucose.
Outcomes: After treatments, her fatigue symptoms were reduced, blood potassium and magnesium levels were increased, and blood glucose levels were well controlled.
Lessons: When GS is considered in patients with unexplained hypokalemia, the HCT test can be used for differential diagnosis, and genetic testing can be continued to confirm the diagnosis when conditions are available. GS patients often have abnormal glucose metabolism, which is mainly caused by hypokalemia, hypomagnesemia, and secondary activation of RAAS. When a patient is diagnosed with GS and type 2 diabetes, sodium-glucose cotransporter 2 inhibitors (SGLT2i) can be used to control the blood glucose level and assist in raising blood magnesium.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270490 | PMC |
| http://dx.doi.org/10.1097/MD.0000000000033959 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Polymyxin-B induced Bartter-like syndrome: an unusual adverse effect.
Ann Med Surg (Lond)
December 2024
Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Introduction And Importance: Bartter syndrome is a rare autosomal recessive disorder affecting renal tubular function leading to disturbances in electrolyte and volume homeostasis. It can also manifest as Bartter-like syndrome (BLS), a rare side effect of certain medications. Polymyxin-B, an antibiotic used to treat multidrug-resistant infections is infrequently associated with BLS.
View Article and Find Full Text PDFGitelman syndrome patient managed with amiloride during pregnancy and lactation.
BMC Nephrol
November 2024
Nephrology Division, Department of Internal Medicine, University of Utah Health, Salt Lake City, USA.
Article Synopsis
- Gitelman Syndrome (GS) is a rare genetic disorder that leads to low potassium and magnesium levels, alongside other metabolic issues, and presents unique challenges in managing these conditions during pregnancy.
- A case study of a 20-year-old woman with GS highlights the use of amiloride, a medication typically used for GS, to successfully manage her persistent low potassium levels during pregnancy and lactation.
- The treatment with amiloride effectively controlled her symptoms without causing any harmful effects on her newborn, suggesting potential safety for the mother and child under careful management.
Proton pump inhibitor-induced hypomagnesemia, a rare cause of reversible delirium: A case report with literature review.
Medicine (Baltimore)
October 2024
Department of Endocrinology, Tianjin Medical University General Hospital, Tianjin, China.
Article Synopsis
- Hypomagnesemia can lead to serious electrolyte imbalances and neurological symptoms, including delirium, which may be linked to the use of proton pump inhibitors (PPIs) like omeprazole.
- A case study of a 74-year-old woman highlighted that despite normal parathyroid hormone levels, she experienced hypomagnesemia and hypocalcemia, leading to delirium and nausea.
- After discontinuing the PPI and administering magnesium, calcium, and potassium supplements, her symptoms improved, emphasizing the need for clinicians to recognize the potential risks of PPIs and monitor magnesium levels.
A missense variant in SLC12A3 gene enhances aberrant splicing causing Gitelman syndrome.
Clin Chim Acta
January 2025
Department of Pathology, Queen Mary Hospital, Hong Kong SAR, China; Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Electronic address:
Article Synopsis
- Gitelman syndrome (GS) is a genetic condition that leads to electrolyte imbalances, mainly due to a mutation in the SLC12A3 gene, resulting in issues like low potassium and magnesium levels.
- A case study in an asymptomatic pregnant woman revealed she had hypokalemia, and genetic testing showed two mutations in the SLC12A3 gene, one of which is confirmed to be harmful.
- The study also found that one of the mutations can create two different messenger RNA transcripts, potentially affecting chloride transport, showing how one mutation can influence the expression of another gene region.
Unveiling atypical diagnoses: when whole-genome analysis performed for refractory infantile hypomagnesemia reveals primary hyperoxaluria.
Pediatr Nephrol
January 2025
Pediatric Nephrology Rheumatology Dermatology Unit, Reference Center for Rare Renal Diseases, ORKID and ERK-Net Networks, Lyon University Hospital, Bron, France.
Article Synopsis
- Genetic testing plays a vital role in diagnosing inherited kidney diseases, as demonstrated by the case of a premature boy with complex tubulopathy who was unexpectedly diagnosed with primary hyperoxaluria type 1 (PH1).
- Despite initial treatments, the patient experienced persistent electrolyte imbalances and progressive kidney issues, prompting comprehensive genetic analysis.
- The identification of mutations in the AGXT gene led to the correct diagnosis, highlighting the importance of thorough genetic evaluations, especially in unusual cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!